Coronado Biosciences Inc (CNDO) Return on Assets ROA from the fourth quarter of 2014 to fourth quarter of and for the year 2014, Average High and Low, Fundamental Ratios from Dec 31 2014 to - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Coronado Biosciences Inc  (CNDO)


Coronado Biosciences Inc's ROA from the fourth quarter of 2014 to the fourth quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Coronado Biosciences Inc's ROA in the fourth quarter of 2014?
Coronado Biosciences Inc achieved a return on average assets (ROA) of 57.63 % in its fourth quarter of 2014, this is above CNDO's average return on assets of 0%.
Coronado Biosciences Inc assets over the 12 months ending in its fourth quarter of 2014 are valued at $47 million

ROA has improved compared to -38.97% in the fourth quarter of 2013, due to net income growth.

However, within the Healthcare sector Coronado Biosciences Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the fourth quarter of 2013 at no. .

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2014)
IV. Quarter		 (Dec 31 2013)
IV. Quarter


Y / Y Total Assets Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 27 -10 0 0 0
Return On Assets (TTM) 57.63 % -38.97 % - - -
CNDO's Total Ranking # # # # #
Total Assets (TTM) in million 89 101 0 0 0
Seq. Total Assets Change -11.19 % - - - -
Seq. Net Income Change - - - - -

CNDO's 5 Years Annual ROA >> Back to CNDO Management Effectiveness >> Compare CNDO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Assets Statistics
High Average Low
0 %
0 %
0 %
 





Financial Statements
Coronado Biosciences Inc's Assets $ 89 million CNDO's Balance sheet
Coronado Biosciences Inc's Income $ 37 million Quarterly CNDO's Income Statement
CNDO's Income by Division See CNDO's Income by Division



Annual Return On Assets (Dec 31 2014)
FY 2014		 (Dec 31 2013)
FY 2013
FY
FY
FY
Y / Y Total Assets Change -11.19 % - - - -
Total Assets in million 89 101 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -20 -37 0 0 0
Annual Return On Assets -22.82 % -36.94 % - - -

CNDO's 5 Years Annual ROA >> Back to CNDO Management Effectiveness >> Compare CNDO ROA to its Competitors



More Return On Assets Ratios
CNDO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CNDO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CNDO's Competitors
Subscribers only: Roa for Coronado Biosciences Inc's Suppliers
Subscribers only: Return On Assets for CNDO's Customers

You may also want to know
CNDO's Roi CNDO's Inventory Turnover Ratio CNDO's Growth Rates CNDO's Dividend Comparisons
CNDO's Profitability Ratios CNDO's Asset Turnover Ratio CNDO's Dividend Growth
CNDO's Roe CNDO's Valuation Ratios CNDO's Financial Strength Ratios CNDO's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2014, within Healthcare Sector ROA
Armata Pharmaceuticals Inc   143.37 %
Tuhura Biosciences Inc   117.81 %
Viskase Holdings inc   113.50 %
Brainstorm Cell Therapeutics inc   97.25 %
Earth Science Tech Inc   96.37 %
Glucotrack Inc   83.36 %
Lumos Pharma Inc   82.23 %
Enanta Pharmaceuticals Inc  56.55 %
Zivo Bioscience Inc   54.25 %
Pacific Health Care Organization Inc  43.45 %
Eternity Healthcare Inc.  40.01 %
Gilead Sciences Inc   39.28 %
Eyepoint Inc   35.92 %
Astrotech Corp  35.60 %
Lannett Company Inc  34.90 %
Pfenex Inc   32.53 %
Agile Therapeutics Inc  32.44 %
Scientific Industries Inc   31.75 %
Medifirst Solutions, Inc.  30.38 %
Oramed Pharmaceuticals Inc  28.81 %
Iridex Corp  28.75 %
Bioage Labs Inc   27.79 %
Edwards Lifesciences Corporation  25.24 %
Luna Innovations Inc  22.32 %
Assertio Holdings inc   22.14 %
Biogen Inc   22.13 %
Ani Pharmaceuticals Inc  22.05 %
China Biologic Products Holdings Inc   21.51 %
Tenax Therapeutics Inc   21.37 %
Adverum Biotechnologies Inc   21.18 %

Date modified: 2026-09-08T15:08:24+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.